resiquimod has been researched along with Autoimmune Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, WH; Hwang, YS; Lee, MH; Liu, CL; Lo, SM; Shen, CN; Shen, CR; Yang, WC | 1 |
| Hengge, UR; Meykadeh, N | 1 |
2 other study(ies) available for resiquimod and Autoimmune Diseases
| Article | Year |
|---|---|
Inhibiting TLR7 Expression in the Retinal Pigment Epithelium Suppresses Experimental Autoimmune Uveitis.
Topics: Animals; Autoimmune Diseases; Disease Models, Animal; Gene Expression Regulation; Imidazoles; Membrane Glycoproteins; Mice; Retinal Pigment Epithelium; Signal Transduction; Toll-Like Receptor 7; Uveitis | 2021 |
[Topical immunomodulators in dermatology].
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts | 2003 |